Norbert Beier Selected Research

EMD 638683

1/2013	Inhibition of colonic tumor growth by the selective SGK inhibitor EMD638683.
1/2011	EMD638683, a novel SGK inhibitor with antihypertensive potency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Norbert Beier Research Topics

Disease

2	Heart Failure 11/2015 - 01/2004
2	Necrosis 11/2015 - 04/2005
2	Cardiomyopathies (Cardiomyopathy) 11/2015 - 04/2005
2	Carcinoma (Carcinomatosis) 01/2013 - 01/2011
2	Body Weight (Weight, Body) 01/2011 - 02/2005
2	Insulin Resistance 05/2008 - 02/2005
2	Hypertrophy 04/2005 - 01/2004
1	Cardiomegaly (Heart Hypertrophy) 11/2015
1	Muscular Dystrophies (Muscular Dystrophy) 11/2015
1	Inflammation (Inflammations) 06/2014
1	Neoplasms (Cancer) 01/2013
1	Carcinogenesis 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011
1	Hyperinsulinism (Hyperinsulinemia) 01/2011
1	Hypertension (High Blood Pressure) 01/2011
1	Edema (Dropsy) 05/2008
1	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2005
1	Obesity 02/2005
1	Atrial Remodeling 04/2004
1	Myocardial Infarction 01/2004
1	Infarction (Infarctions) 01/2004

Drug/Important Bio-Agent (IBA)

4	N- (2- methyl- 4,5- bis(methylsulfonyl)benzoyl)guanidineIBA 11/2015 - 01/2004
2	EMD 638683IBA 01/2013 - 01/2011
2	SodiumIBA 04/2005 - 01/2004
1	CilazaprilIBA 11/2015
1	Sodium-Hydrogen ExchangersIBA 11/2015
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2015
1	C-Reactive ProteinIBA 06/2014
1	EnzymesIBA 06/2014
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2013
1	FITC-annexin A5IBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	GlucocorticoidsIBA 01/2013
1	PhosphatidylserinesIBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2013
1	Propidium (Propidium Iodide)IBA 01/2013
1	Dextran SulfateIBA 01/2013
1	Annexin A5IBA 01/2013
1	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 01/2013
1	Caspase 3 (Caspase-3)IBA 01/2013
1	Drinking WaterIBA 01/2013
1	Vasodilator Agents (Vasodilators)IBA 02/2012
1	SaltsIBA 01/2011
1	Glucose (Dextrose)FDA LinkGeneric 05/2008
1	PPAR gammaIBA 05/2008
1	growth factor-activatable Na-H exchanger NHE-1IBA 04/2005
1	Fibronectins (Fibronectin)IBA 04/2005
1	1,1'- ((4,4,7,7- tetramethyl)- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- oxazole)- 2- methylidene)quinolinium (YOYO)IBA 02/2005
1	CarbohydratesIBA 02/2005
1	salicylhydroxamic acid (SHAM)IBA 01/2004
1	HydrogenIBA 01/2004
1	Atrial Natriuretic Factor (ANF)IBA 01/2004

Therapy/Procedure

1	Intraperitoneal Injections 01/2013
1	Therapeutics 02/2012
1	Ligation 01/2004
1	Treatment Delay 01/2004